Highly constrained bicyclic VLA-4 antagonists

Bioorg Med Chem Lett. 2007 Feb 1;17(3):597-601. doi: 10.1016/j.bmcl.2006.11.011. Epub 2006 Nov 7.

Abstract

VLA-4 is implicated in several inflammatory and autoimmune disease states. A series of cyclic beta-amino acids (beta-aa) was studied as VLA-4 antagonists. Binding affinity was highly dependent on the dihedral angle (phi) between the amino and the carboxyl termini of the beta-aa. Compound 5 m where the beta-aa is embedded in a bicycle possesses the most preferred phi (120 degrees). It is a potent and bioavailable VLA-4 antagonist (VCAM-Ig alpha4beta1 IC50 = 54 nM, rat po F = 49%).

MeSH terms

  • Biological Availability
  • Bridged Bicyclo Compounds / chemical synthesis*
  • Bridged Bicyclo Compounds / pharmacokinetics
  • Bridged Bicyclo Compounds / pharmacology*
  • Half-Life
  • Humans
  • Indicators and Reagents
  • Integrin alpha4beta1 / antagonists & inhibitors*
  • Integrins / metabolism
  • Jurkat Cells
  • Magnetic Resonance Spectroscopy
  • Molecular Conformation
  • Stereoisomerism
  • Structure-Activity Relationship
  • Vascular Cell Adhesion Molecule-1 / metabolism

Substances

  • Bridged Bicyclo Compounds
  • Indicators and Reagents
  • Integrin alpha4beta1
  • Integrins
  • Vascular Cell Adhesion Molecule-1